XML 34 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Equity - CAD ($)
$ in Millions
Total
Preferred shares and other equity [Member]
Common shares [Member]
Shareholders and other equity holders retained earnings [Member]
Contributed Surplus [Member]
Shareholders' accumulated other comprehensive income (loss) ("AOCI") [Member]
Participating Policyholders' Equity [Member]
Non-controlling Interests [Member]
Balance, beginning of year at Dec. 31, 2020   $ 3,822 $ 23,042 $ 18,887 $ 261 $ 6,323 $ (784) $ 1,455
Issued (note 12)   3,200            
Redeemed (note 12)   (612)            
Issuance costs, net of tax   (29)            
Exercise of stock options and deferred share units     51   (8)      
Stock option expense         9      
Net income attributed to shareholders and other equity holders       7,105        
Preferred share dividends and other equity distributions       (215)        
Preferred shares redeemed (note 12)       (13)        
Common share dividends       (2,272)        
Change in unrealized foreign exchange gains (losses) on net foreign operations $ (514)         (414)    
Change in actuarial gains (losses) on pension and other post-employment plans 199         199    
Change in unrealized gains (losses) on available-for-sale financial securities (980)         (989)    
Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges 77         73    
Change in real estate revaluation reserve (11)         (11)    
Share of other comprehensive income (losses) of associates (1)         (1)    
Net income (loss) attributed to participating policyholders (448)           (448)  
Net income attributed to non-controlling interests 255             255
Other comprehensive income (loss) attributed to policyholders and non-controlling interests             (1) (3)
Contributions (distributions and acquisition), net               (13)
Balance, end of year at Dec. 31, 2021 58,869 6,381 23,093 23,492 262 5,180 (1,233) 1,694
Total shareholders' and other equity, end of year 58,408              
Issued (note 12)   1,000            
Redeemed (note 12)   (711)            
Issuance costs, net of tax   (10)            
Exercise of stock options and deferred share units     23   (4)      
Stock option expense         5      
Net income attributed to shareholders and other equity holders       7,294        
Common shares repurchased (note 12)     (938) (946)        
Preferred share dividends and other equity distributions       (260)        
Preferred shares redeemed (note 12)       (14)        
Common share dividends       (2,513)        
Change in unrealized foreign exchange gains (losses) on net foreign operations 2,350         1,935    
Change in actuarial gains (losses) on pension and other post-employment plans 17         17    
Change in unrealized gains (losses) on available-for-sale financial securities (7,608)         (7,315)    
Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges 161         164    
Change in real estate revaluation reserve (1)         (1)    
Share of other comprehensive income (losses) of associates (5)         (5)    
Net income (loss) attributed to participating policyholders (111)           (111)  
Net income attributed to non-controlling interests (1)             (1)
Other comprehensive income (loss) attributed to policyholders and non-controlling interests             (2) (3)
Contributions (distributions and acquisition), net               (26)
Acquisition of non-controlling interest       (43) (25)      
Balance, end of year at Dec. 31, 2022 56,379 $ 6,660 $ 22,178 $ 27,010 $ 238 $ (25) $ (1,346) $ 1,664
Total shareholders' and other equity, end of year $ 56,061